Sökning: onr:"swepub:oai:lup.lub.lu.se:922fb88b-c459-4011-8876-fd94a5170d0e" > Clinical impact of ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07258naa a2200841 4500 | |
001 | oai:lup.lub.lu.se:922fb88b-c459-4011-8876-fd94a5170d0e | |
003 | SwePub | |
008 | 160401s2001 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:1960981 | |
024 | 7 | a https://lup.lub.lu.se/record/11221952 URI |
024 | 7 | a https://doi.org/10.1002/gcc.11552 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:19609812 URI |
040 | a (SwePub)lud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Panagopoulos, Iu Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kgen-ipa |
245 | 1 0 | a Clinical impact of molecular and cytogenetic findings in synovial sarcoma |
264 | c 2001-06-07 | |
264 | 1 | b Wiley,c 2001 |
300 | a 11 s. | |
520 | a Synovial sarcoma is an aggressive soft-tissue tumor that accounts for up to 10% of soft-tissue sarcomas. Cytogenetically, synovial sarcoma is characterized by the t(X;18)(p11;q11), found in more than 95% of the tumors. This translocation results in rearrangements of the SYT gene in 18q11 and one of the SSX1, SSX2, or SSX4 genes in Xp11, creating a SYT/SSX1, SYT/SSX2, or SYT/SSX4 chimeric gene. It has been shown that patients with SYT/SSX1 fusion genes have a shorter metastasis-free survival than do patients with SYT/SSX2. Previous studies have also suggested that clonal evolution may be associated with disease progression. In the present study, RT-PCR analysis showed that all 64 examined synovial sarcomas from 54 patients had SYT-SSX chimeric genes. SYT/SSX1 was found in 40 tumors from 33 patients, SYT/SSX2 in 23 tumors from 20 patients, and SYT/SSX4 in one case. Two patients had variant SYT/SSX2 transcripts, with 57 bp and 141 bp inserts, respectively, between the known SYT and SSX2 sequences. Patients with tumors with SYT/SSX1 fusions had a higher risk of developing metastases compared to those with SYT/SSX2 fusions (P = 0.01). The reciprocal transcripts SSX1/SYT and SSX2/SYT were detected using nested PCR in 11 of the 40 samples with SYT/SSX1 and 5 of the 23 samples with SYT/SSX2, respectively. Among 20 blood samples, SYT/SSX1 and SYT/SSX2 were detected in one sample each. The t(X;18), or variants thereof, was found cytogenetically in all patients but three. Among 32 primary tumors, the t(X;18) or a variant translocation was the sole anomaly in 10. In contrast, of the seven metastatic lesions that were investigated prior to radiotherapy, only one had a t(X;18) as the sole anomaly; all other tumors displayed complex karyotypes. Cytogenetic complexity in primary tumors was, however, not associated with the development of metastases. Tumors with SYT/SSX2 less often (4/12 vs. 7/15) showed complex karyotypes than did tumors with SYT/SSX1, but the difference was not significant. Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases). This corresponded to 5-year metastasis-free survival rates of 0.58 and 0.0, respectively (P = 0.02). | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Adolescent | |
653 | a Adult | |
653 | a Aged | |
653 | a Aged, 80 and over | |
653 | a Amino Acid Sequence | |
653 | a Base Sequence | |
653 | a Child | |
653 | a Female | |
653 | a Humans | |
653 | a Karyotyping | |
653 | a Male | |
653 | a Middle Aged | |
653 | a Molecular Sequence Data | |
653 | a Neoplasm Proteins | |
653 | a Oncogene Proteins, Fusion | |
653 | a Proteins | |
653 | a Proto-Oncogene Proteins | |
653 | a Repressor Proteins | |
653 | a Sarcoma, Synovial | |
653 | a Sequence Analysis, DNA | |
653 | a Soft Tissue Neoplasms | |
653 | a Journal Article | |
653 | a Research Support, Non-U.S. Gov't | |
700 | 1 | a Mertens, Fu Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kgen-fme |
700 | 1 | a Isaksson, Margarethu Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kgen-mis |
700 | 1 | a Limon, J4 aut |
700 | 1 | a Gustafson, Pelleu Lund University,Lunds universitet,Ortopedi, Lund,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Orthopaedics (Lund),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)ort-pgu |
700 | 1 | a Skytting, B4 aut |
700 | 1 | a Åkerman, Månsu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pat-mak |
700 | 1 | a Sciot, R4 aut |
700 | 1 | a Dal Cin, P4 aut |
700 | 1 | a Samson, I4 aut |
700 | 1 | a Iliszko, M4 aut |
700 | 1 | a Ryoe, J4 aut |
700 | 1 | a Dêbiec-Rychter, M4 aut |
700 | 1 | a Szadowska, A4 aut |
700 | 1 | a Brosjö, Ou Karolinska Institutet4 aut |
700 | 1 | a Larsson, Ou Karolinska Institutet4 aut |
700 | 1 | a Rydholm, Au Lund University,Lunds universitet,Ortopedi, Lund,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Ortopedisk sarkomforskning,Forskargrupper vid Lunds universitet,Orthopaedics (Lund),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Orthopaedic Sarcoma Research,Lund University Research Groups4 aut0 (Swepub:lu)ort-ary |
700 | 1 | a Mandahl, Nu Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kgen-nma |
710 | 2 | a Avdelningen för klinisk genetikb Institutionen för laboratoriemedicin4 org |
773 | 0 | t Genes, Chromosomes and Cancerd : Wileyg 31:4, s. 72-362q 31:4<72-362x 1045-2257 |
856 | 4 | u http://dx.doi.org/10.1002/gcc.1155y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/1122195 |
856 | 4 8 | u https://doi.org/10.1002/gcc.1155 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:1960981 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.